Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator-Sponsored, Open-Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection

NCT04100447 is registered in ClinicalTrials.gov with Ronald Hurst, MD, FACS as lead sponsor.

NCT NCT04100447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04100447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator-Sponsored, Open-Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection
Lead sponsor
Ronald Hurst, MD, FACS
Phase
Phase 1
Overall status
Completed
Start date
November 5, 2018
Completion date
December 1, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhesions, ileus